http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

4th Annual Drug Development Forum

This week's FierceLifeSci is brought to you by ExL Events.

Trouble viewing? Click here.
4th Drug Development Forum
 

Dear E,

We are excited to announce the release of the agenda for the 4th FierceBiotech Drug Development Forum, taking place on October 28–29 at the Colonnade Hotel in Boston!
 
 

BROCHURE IS NOW AVAILABLE
Brochure Download
 

This conference provides a unique networking opportunity, featuring insights from C-suite and executive leadership at biotech, mid-sized, and large pharma companies on two distinct tracks, addressing the strategic and operational challenges in the following areas:

  • Deal-Making and Business Strategy: This track will highlight how to map out the right financing strategy for your company and share best practices for mitigating risks and unlocking the potential of partnerships, licensing deals, and M&A transactions
  • Product Development Strategy: This track will cover the end-to-end drug development process, focusing on early R&D, clinical development, and the complexities of product commercialization up through launch

Featured Speakers
 
 
Sandy Macrae

Sandy Macrae,
CEO, SANGAMO THERAPEUTICS
 
 
Pearl S. Huang

Pearl S. Huang, Ph.D.,
President and CEO, CYGNAL THERAPEUTICS
 
 
Lizabeth Leveille

Lizabeth Leveille,
Associate Vice President and Head, Boston Innovation Hub, BD&L, MERCK
 
 
James Robinson

James Robinson,
President and Chief Operating Officer, PARAGON BIOSCIENCES
 
 
Emily Minkow

Emily Minkow,
Chief Business Officer, PREVAIL THERAPEUTICS
 
 
Elliott M. Levy

Elliott M. Levy, M.D.,
Senior Vice President, Global Development, AMGEN
 
 
David Weinreich

David Weinreich, M.D., MBA,
Senior Vice President, Global Clinical Development, REGENERON
 
 
Molly Harper

Molly Harper,
Senior Vice President and Global Franchise General Manager, AKCEA THERAPEUTICS
 
 
Lotus Mallbris

Lotus Mallbris, M.D., Ph.D.,
Vice President, Immunology Development, ELI LILLY AND COMPANY
 
 
Robert Bagdorf

Robert Bagdorf, M.D., MBA,,
Group Lead, Search and Evaluation, Worldwide Business Development, PFIZER
 
 
Kleem Chaudhary

Kleem Chaudhary, Ph.D.,,
Head BD&L, BIOGEN
 
 
Rich Daly

Rich Daly,
Chief Operating Officer, BEYONDSPRING PHARMACEUTICALS
 

With multiple tracks to choose from, the 4th FierceBiotech Drug Development Forum provides a unique opportunity for your team to tailor your educational experience and engage with the brightest minds in biotech and big pharma.

Click here to register your team today and take advantage of our special Early Bird discounts, which expire September 13, 2019. Use Discount Code FIERCE100 and be sure to mention Priority Code 794219EM2 when signing up.

We look forward to meeting you in Boston!

Best regards,

Zohaib Sheikh
Senior Conference Director
ExL Events, a division of Questex, LLC
 

Rebecca Willumson
Publisher 
FierceBiotech
 

For information on sponsorship opportunities, please contact Shauna Greig at sgreig@questex.com or 212-400-6228.
 
 



Want to reach 216,000+ FierceLifeSci Weekly subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.



About this email: In order to receive FierceLifeSci Weekly for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceLifeSci Weekly.
Click here to unsubscribe. Refer to our Privacy Policy.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036